Zevra Therapeutics (ZVRA) Financials: Revenue & Earnings

ZVRA price $10.16 +0.10 +1.00%

Ticker
ZVRA
Price
$10.16
Change
+0.10 +1.00%
Market cap ?
$603.10M
Beta ?
0.98
Sector
Healthcare
Industry
Biotechnology

Fair value

ZVRA fair value $38.44. Price $10.16. Price is 74% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Model uncertainty high for this stock

Compare ZVRA

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-03—0.14—37.08M
2026-08-050.140.1139.66M33.88M
2026-05-060.600.0636.22M31.96M
2026-03-090.210.0534.10M28.05M
2025-11-05-0.01-0.0226.06M26.64M
2025-08-121.212.1925.88M24.52M
2025-05-13-0.06-0.2120.40M21.07M
2025-03-11-0.67-0.3912.04M16.66M
2024-11-12-0.69-0.443.69M8.78M
2024-08-13-0.48-0.474.45M4.36M
2024-05-08-0.40-0.493.42M4.65M
2024-03-28-0.40-0.2013.22M11.74M
2023-11-07-0.40-0.292.90M10.95M
2023-08-14-0.15-0.398.47M3.03M
2023-05-15-0.34-0.262.88M2.65M
2023-03-07-0.26-0.212.32M3.11M
2022-11-09-0.19-0.132.87M3.01M
2022-08-11-0.70-0.121.30M1.75M
2022-05-12-0.05-0.053.96M3.06M
2022-03-30-0.08-0.072.58M2.23M
2021-11-10-0.05-0.071.97M—
2021-08-120.210.2311.99M—
2021-05-13-0.54-0.1712.12M—
2021-03-11-1.07-0.642.37M—
2020-10-29-0.64-0.801.93M—
2020-08-120.16—6.91M—
2020-05-12-1.760.162.09M—
2020-02-28-0.16-1.361.38M—
2019-11-140.96-2.9911.46M—
2019-08-13-5.28-6.80——
2019-05-14-7.36-7.36——
2019-02-28-3.20-8.44——
2018-11-08-15.04-12.32——
2018-08-09-14.56-15.42——
2018-05-10-28.32-11.16——
2018-03-29-11.52-10.96——
2017-11-09-10.88-10.76——
2017-08-10-7.04-10.08——
2017-05-10-13.44-10.08——
2017-03-09-10.88-11.15——

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-10-12McFarlane Neil F.Sell20.00K$11.25224.95K
2026-10-10McFarlane Neil F.Buy50.00K——
2026-10-10McFarlane Neil F.Sell50.00K——
2026-08-14Thompson RahsaanSell42.67K$11.13474.77K
2026-08-10Watton Corey MichaelSell12.30K$4.9761.13K
2026-08-10Watton Corey MichaelBuy12.30K$4.9761.13K
2026-08-10Watton Corey MichaelSell12.30K$11.25138.38K
2026-06-22Thompson RahsaanSell34.56K$12.68438.30K
2026-06-21Thompson RahsaanBuy66.67K——
2026-06-21Thompson RahsaanSell66.67K——
2026-06-04FAVORITO TAMARA ABuy30.00K$11.17335.10K
2026-06-04Secor AliciaBuy30.00K$11.17335.10K
2026-06-04Watton Corey MichaelBuy30.00K$11.17335.10K
2026-06-04Calder Douglas WBuy30.00K$11.17335.10K
2026-06-04Anderson ThomasBuy30.00K$11.17335.10K
2026-06-04Shih AlvinBuy30.00K$11.17335.10K
2026-05-28Sangiovanni Timothy J.Buy40.00K$11.40456.00K
2026-05-28Sangiovanni Timothy J.Buy20.00K——
2026-05-11Thompson RahsaanSell1.79K$11.3020.27K
2026-03-24Bode John BBuy39.20K$4.89191.69K
2026-03-24Bode John BBuy39.20K$4.97194.82K
2026-03-24Bode John BSell39.20K$4.97194.82K
2026-03-24Bode John BSell39.20K$4.89191.69K
2026-03-18Renz Justin ABuy300.00K$9.552.87M
2026-03-18Renz Justin AOther0——
2026-02-09McFarlane Neil F.Sell14.62K$8.56125.19K
2026-02-07McFarlane Neil F.Buy37.50K——
2026-02-07McFarlane Neil F.Sell37.50K——
2026-02-03Sangiovanni Timothy J.Sell3.00K$9.1827.55K
2026-02-03Schafer JoshuaSell10.50K$9.1996.50K
2026-02-02McFarlane Neil F.Sell91.00K$9.38853.43K
2026-01-31Sangiovanni Timothy J.Buy11.67K——
2026-01-31Sangiovanni Timothy J.Sell11.67K——
2026-01-31Schafer JoshuaBuy35.33K——
2026-01-31Schafer JoshuaSell35.33K——
2026-01-31McFarlane Neil F.Buy233.33K——
2026-01-31McFarlane Neil F.Sell233.33K——
2026-01-30Sangiovanni Timothy J.Buy6.33K——
2026-01-30Sangiovanni Timothy J.Sell1.75K$8.8215.44K
2026-01-30Sangiovanni Timothy J.Sell6.33K——
2026-01-30Thompson RahsaanBuy11.33K——
2026-01-30Thompson RahsaanSell4.08K$8.8336.01K
2026-01-30Thompson RahsaanSell11.33K——
2026-01-30Quartel Adrian WSell11.33K——
2026-01-30Quartel Adrian WBuy11.33K——
2026-01-30Quartel Adrian WSell4.53K$8.8340.04K
2026-01-30Schafer JoshuaBuy11.33K——
2026-01-30Schafer JoshuaSell3.38K$8.8329.80K
2026-01-30Schafer JoshuaSell11.33K——
2026-01-29Thompson RahsaanBuy75.00K$8.86664.50K
2026-01-29Thompson RahsaanBuy37.50K——
2026-01-29Quartel Adrian WBuy75.00K$8.86664.50K
2026-01-29Quartel Adrian WBuy37.50K——
2026-01-29Schafer JoshuaBuy75.00K$8.86664.50K
2026-01-29Schafer JoshuaBuy37.50K——
2026-01-29McFarlane Neil F.Buy250.00K$8.862.21M
2026-01-29McFarlane Neil F.Buy125.00K——
2025-12-31Clifton R. LaDuaneBuy140.67K——
2025-12-31Clifton R. LaDuaneSell48.51K$8.96434.68K
2025-12-31Clifton R. LaDuaneSell20.00K——
2025-12-31Clifton R. LaDuaneSell34.00K——
2025-12-02Secor AliciaBuy45.00K$8.17367.65K
2025-12-02Secor AliciaOther0——
2025-10-10McFarlane Neil F.Buy50.00K——
2025-10-10McFarlane Neil F.Sell19.50K$10.82210.91K
2025-10-10McFarlane Neil F.Sell50.00K——
2025-09-12FAVORITO TAMARA ABuy3.17K$7.7924.72K
2025-09-12Shih AlvinBuy20.00K$7.89157.80K
2025-08-19Bode John BBuy5.00K$9.1645.82K
2025-06-26Thompson RahsaanSell24.00K$9.21221.00K
2025-06-21Thompson RahsaanSell66.67K——
2025-06-21Thompson RahsaanBuy66.67K——
2025-05-29Shih AlvinBuy30.00K$8.62258.60K
2025-05-29DIXON WENDY LBuy30.00K$8.62258.60K
2025-05-29Calder Douglas WBuy30.00K$8.62258.60K
2025-05-29FAVORITO TAMARA ABuy30.00K$8.62258.60K
2025-05-29Watton Corey MichaelBuy30.00K$8.62258.60K
2025-05-29Bode John BBuy30.00K$8.62258.60K
2025-05-29Anderson ThomasBuy30.00K$8.62258.60K
2025-03-28Watton Corey MichaelBuy300$7.842.35K
2025-03-19Bode John BBuy10.00K$7.9679.62K
2025-02-14McFarlane Neil F.Sell30.54K$8.05245.96K
2025-02-13Sangiovanni Timothy J.Sell3.00K$7.8623.59K
2025-02-13Schafer JoshuaSell10.50K$7.8682.53K
2025-02-13Clifton R. LaDuaneSell11.00K$7.8686.47K
2025-02-13McFarlane Neil F.Sell61.27K$7.86481.43K
2025-02-07McFarlane Neil F.Buy225.00K$7.771.75M
2025-02-07McFarlane Neil F.Buy112.50K——
2025-01-31Sangiovanni Timothy J.Sell11.67K——
2025-01-31Sangiovanni Timothy J.Buy11.67K——
2025-01-31Schafer JoshuaSell35.33K——
2025-01-31Schafer JoshuaBuy35.33K——
2025-01-31Clifton R. LaDuaneSell43.33K——
2025-01-31Clifton R. LaDuaneBuy43.33K——
2025-01-31McFarlane Neil F.Sell233.33K——
2025-01-31McFarlane Neil F.Buy233.33K——
2025-01-30Quartel Adrian WBuy68.00K$8.02545.36K
2025-01-30Quartel Adrian WBuy34.00K——
2025-01-30Sangiovanni Timothy J.Buy38.00K$8.02304.76K
2025-01-30Sangiovanni Timothy J.Buy19.00K——

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 168, holders +10 vs prior quarter. Ownership 77.06%.

HolderSharesChangeChange %Value
BLACKROCK, INC.5.11M652.39K+14.64%73.26M
FMR LLC4.92M1.70M+53.05%70.49M
WOODLINE PARTNERS LP4.79M1.33M+38.68%68.63M
VANGUARD CAPITAL MANAGEMENT LLC2.64M169.58K+6.87%37.84M
CAPTION MANAGEMENT, LLC2.00M1.91M+2005.99%28.72M
NANTAHALA CAPITAL MANAGEMENT, LLC1.80M-724.46K-28.73%25.78M
STATE STREET CORP1.68M120.43K+7.71%24.12M
GEODE CAPITAL MANAGEMENT, LLC1.54M169.08K+12.32%22.10M
D. E. SHAW & CO., INC.1.31M460.49K+54.40%18.74M
QUBE RESEARCH & TECHNOLOGIES LTD1.24M399.02K+47.37%17.80M
MORGAN STANLEY1.20M11.61K+0.97%17.26M
LEGAL & GENERAL GROUP PLC1.20M38.58K+3.32%17.23M
DIMENSIONAL FUND ADVISORS LP958.84K404.03K+72.82%13.75M
ROYCE & ASSOCIATES LP882.66K-106.02K-10.72%12.66M
683 CAPITAL MANAGEMENT, LLC855.00K-120.00K-12.31%12.26M
KINGDON CAPITAL MANAGEMENT, L.L.C.775.00K00.00%11.11M
RETIREMENT PLANNING CO OF NEW ENGLAND, INC.634.41K-16.74K-2.57%9.10M
JUPITER TOPCO LLC613.40K613.40KNew8.80M
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP597.16K597.16KNew8.56M
GOLDMAN SACHS GROUP INC545.55K521.95K+2211.66%7.82M
VANGUARD PORTFOLIO MANAGEMENT LLC541.11K74.81K+16.04%7.76M
NORTHERN TRUST CORP486.50K49.55K+11.34%6.98M
SWEDBANK AB439.41K439.41KNew6.30M
SCHRODER INVESTMENT MANAGEMENT GROUP439.33K-66.70K-13.18%6.15M
TUDOR INVESTMENT CORP ET AL415.06K282.36K+212.78%5.95M

Earnings and financials

Zevra Therapeutics, Inc. (ZVRA) trades at $10.16, with a market cap of $603.10M and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Zevra Therapeutics (ZVRA) Financials: Revenue & Earnings

ZVRA$10.16+0.10 +1.00%

$603.10M

Market Cap

—

P/E

—

Forward P/E

—

Score

Price History